Breast cancer is one of the most common malignancies worldwide, and mutations in the PI3K/AKT/mTOR (PAM) signaling pathway ...
BLU-222, an investigational, oral, potent, and highly selective CDK2 inhibitor (CDK2i), as monotherapy in patients (pts) with advanced solid tumors and in combination with ribociclib (RIBO) and ...
Neuroblastoma kills more children under one year of age than any other extracranial solid tumor, and high-risk cases have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results